Protons pump inhibitor treatment and lower gastrointestinal bleeding: Balancing risks and benefits
Proton pump inhibitors (PPIs) represent a milestone in the treatment of acid-related diseases, and are the mainstay in preventing upper gastrointestinal bleeding in high-risk patients treated with nonsteroidal anti-inflammatory drugs (NSAIDs) or low-dose aspirin. However, this beneficial effect does...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Baishideng Publishing Group Inc
2016
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192259/ |